IL17A and psoriasis: Interleukin 17 has a significant role in the pathophysiology of psoriasis causing keratinocyte hyperplasia (119, 120), whereas therapeutic administration of antibodies against IL-17 is efficacious in the treatment for psoriasis (121–123).